1. Catalog
  2. CardioBites: Amyloidosis Series
Image For Activity Cover
CardioBites: Amyloidosis Series
Overview - What are CardioBites
CardioBites are mobile-friendly, bite-sized videos providing focused education on important topics in the heart failure field. They can be watched anytime, anywhere on YouTube. No password. No barriers. Just easy access. HFSA will release one CardioBites video each month.

Simply click on the image below to view the episodes and subscribe to the HFSA YouTube channel.

View the full playlist of videos in this series here.
Target Audience
The CardioBites Video Series is designed to educate physicians, scientists, nurses, nurse practitioners, pharmacists, and patients about the recent advances and emerging trends in Heart Failure.
Series Outline
What is Amyloidosis
Amyloidosis (am-uh-loi-DO-sis) is a rare disease that may affect the heart, kidneys, liver, spleen, nervous system and digestive tract. Learn more about this complex and serious condition. YouTube Link.

What are the Signs and Symptoms of Amyloidosis
Amyloidosis (am-uh-loi-DO-sis) is a rare disease that may affect the heart, kidneys, liver, spleen, nervous system and digestive tract. Learn more about this complex and serious condition.  YouTube Link.

What are the Most Common Types of Amyloidosis
Amyloiosis is a rare disease associated with the accumulation of insoluble amyloid fibrils in the body.  Join us as we discuss the different types of amyloidosis and how this condition affects the body.  YouTube Link

What Do We Know About the Genetics of Amyloidosis
Is amyloidosis hereditary?  Is genetic screening necessary?  In this CardioBites, we explore what we know about the genetics of hereditary and wild-type amyloidosis and who is at risk for these conditions.  YouTube Link

How is Amyloidosis Diagnosed
Patients with cardiac amyloidosis often have symptoms suggestive of heart failure with preserved ejection fraction (HFPEF). In our fifth Amyloidosis module, learn how to evaluate these symptoms and diagnose cardiac amyloidosis.  YouTube Link

Treatment and Management of Immunoglobulin Light Chain (AL) Amyloidosis
Treatment of patients with immunoglobulin light chain amyloidosis or AL is based on the degree of cardiac involvement and staging. In this video, we examine staging factors, prognosis, and treatment options for these patients.  YouTube Link

Treatment and Management of Transthyretin-mediated (ATTR) Amyloidosis
The management of patients with transthyretin amyloidosis includes 2 main categories of disease-modifying therapies.  This video discusses the role of TTR stabilizers and TTR silencers/knockdown agents along with heart failure and arrhythmia management for the management of patients with cardiac ATTR.  YouTube Link

Multidisciplinary Care of Amyloidosis
In this module, we explore how a multidisciplinary care team approach can shorten the time to diagnosis, facilitate effective treatment decisions, and improve the quality of care for patients with amyloidosis. YouTube Link

Amyloidosis Treatments on the Horizon
The treatment of transthyretin cardiac amyloisis is evolving rapidly.  In this module, we discuss the new and emerging therapies that can better assist patients in reaching their goals and improving health outcomes.  YouTube Link

Play all CardioBites on Amyloidosis
https://www.youtube.com/playlist?list=PLYL7LwhWMWn3LiS0zFtf9fvLBgsjEzvip

CardioBites FAQs
pdf document link
Bite-sized videos, focus education frequently asked questions.
HFSA YouTube Channel
Subscribe to the HFSA YouTube channel.
Supporter(s)
The Heart Failure Society of America acknowledges Alnylam for providing an independent educational grant to support the HFSA CardioBites: Amyloidosis.
Summary
Cost: FREE
Credit:
No Credit Offered
Create Account
Recommended
Powered by Oasis.